Pregnancy outcomes after exposure to interferon beta in MS
Important information
The following feature is intended for healthcare professionals only. Please tick the box below to confirm that you are a healthcare professional.
This feature is for healthcare professionals only.
Multiple sclerosis (MS) typically starts in the reproductive age and affects more females than males, which means that many people with MS are facing questions related to pregnancy. However, a major challenge is that trial data is lacking because typically, pregnant patients will not have been involved in the clinical trials that investigate drugs for MS treatment. A recent study, published by Therapeutic Advances in Neurological Disorders, focused on pregnancy outcomes after interferon beta exposure before or during (early) pregnancy among people living with MS.
This Publication In Focus discusses the research in detail, including a video with the authors, published by the Video Journal of Biomedicine, the study methods and results in the form of an infographic, and how the findings will help to advance the field of MS and pregnancy in the form of an author podcast.
FEATURES
This infographic visualizes the key objectives, methods, results and conclusions from the recent study investigating pregnancy and MS.
NCTalks with Jan Hillert: pregnancy outcomes in MS
In this podcast, we spoke with Professor Jan Hillert (Karolinska Institute, Sweden) about the challenges faced for people living with MS related to pregnancy and pregnancy outcomes, and how their recent study could help to overcome these challenges.